Canid.

A nurse scans a barcode. The hard part is already done.

In a pediatric office in upstate New York, a nurse holds a vial under a scanner. Beep. The dose is recorded, the inventory updates, the insurance claim queues itself, the state registry gets its report, and the parent gets a follow-up text in Spanish. The nurse never opens a spreadsheet. None of that work disappeared - it just stopped being the practice's problem. That is Canid, working in the background.

Canid is a health technology company based in New York. It does not invent vaccines or administer them. It does the unglamorous middle: buying the vaccines, tracking them, billing for them, proving compliance, and chasing down the families who are overdue. The pitch fits on a t-shirt - "You give vaccines, we do everything else" - and the company seems faintly amused that nobody had bothered to build this before.

The shot costs $0.02 of attention. The paperwork costs the practice.

Vaccines are the second-biggest line item in a pediatric office - right after payroll.

Here is the part nobody puts on a clinic brochure. A vaccine vial is expensive, perishable, and tangled in rules. A practice fronts the cash to stock it, prays the fridge holds, bills an insurer that may quietly deny the claim, and reconciles every dose against a federal program with its own ledger. Get any step slightly wrong and the practice eats the loss.

The numbers are unkind. By the company's own reckoning - drawn from industry data - 69% of pediatricians either break even or lose money on their vaccine programs. Meanwhile the administrative load keeps climbing: pediatricians now spend roughly 15 hours a week on paperwork, up from 9 hours in 2012. The math quietly squeezes independent practices out of existence, one denied claim at a time.

Buy the vaccines yourself. Then nobody can lose money on them.

Founded in 2021 and led by co-founder and CEO Pedro Sánchez de Lozada, Canid made a contrarian wager. Most healthtech startups sell software and let the customer keep the operational risk. Canid did the opposite - it took the risk onto its own balance sheet. The company purchases the vaccines on the practice's behalf, with zero upfront cost to the office, then runs the inventory, billing, and compliance as a managed service.

It is a strange thing for a software company to do: hold perishable inventory and absorb financial exposure. But that is exactly the part pediatricians hate, and exactly where economies of scale pay off. One practice negotiating vaccine purchasing and fighting denials is a rounding error. Hundreds of practices doing it through one platform becomes leverage.

Five jobs the office no longer has to do

Canid integrates directly with the systems pediatric practices already use - eClinicalWorks, Athenahealth, Office Practicum, PCC, Epic, NextGen and more than a dozen others. Once connected, it covers the whole lifecycle of a dose.

What it looks like when the math works

Claims are easy; receipts are harder. Canid's case rests on adoption and scale. The platform reports partnerships with 150+ pediatricians, more than 300,000 children inside partnered patient panels, and over 121,000 patients vaccinated through the system - with the company's later figures citing 500,000+ vaccines managed and 200,000+ patients served as the footprint widened to 18 states.

The Series A investors are a tell of their own. Telescope Partners led; FJ Labs, Brooklyn Bridge Ventures, and SeedtoB joined. These are funds that back operational depth, not buzzwords - a useful signal for a company whose product is, essentially, doing tedious work very reliably.

Keep the small practice alive. Keep the kid vaccinated.

Strip away the software language and Canid is making a public-health argument. When the economics of vaccines punish independent pediatric practices, those practices close or stop stocking certain vaccines - and access shrinks in exactly the communities that can least absorb it. Fix the back office, the reasoning goes, and you protect both the business and the immunization rate.

That is why the outreach tools are bilingual and the compliance work covers the Vaccines for Children program, which serves families who could not otherwise afford vaccines. The mission is not abstract: it is the difference between a clinic that can keep its doors open and one that cannot.

The infrastructure you only notice when it breaks

The best plumbing is invisible. If Canid succeeds, parents will never learn its name, and pediatricians will spend a little less of their week arguing with insurers about a $200 claim. The administrative drag on American pediatrics is not going to lighten on its own; the hours have only climbed since 2012. Someone has to absorb the complexity, and Canid is betting it can do that at a scale no single practice can.

Back in that upstate office, the nurse moves to the next patient. Beep. The vial is recorded, billed, reconciled, and reported before she reaches the door. The hardest part of giving a vaccine - everything that is not the vaccine - has been quietly handled. That was always the point.